Streptococcus mutans LM7 (Bratthall serotype e) chromosomal DNA was partially digested with EcoRI and ligated into the positive-selection plasmid vector pOP203(A2+). The ligation mixture was transformed into Escherichia coli, and transformants were selected for tetracycline resistance. Recombinant-bearing clones were screened for their ability to ferment raffinose, ,using the procedure of Robeson et al. (J. Bacteriol. 153:211-221, 1983 
Streptococcus mutans is recognized as a primary causative agent of dental caries (11, 24) . Two characteristics responsible for the pathogenicity of this organism are (i) its ability to colonize the hard tooth surface (12, 14) and (ii) its ability to produce large amounts of lactic acid from fermentable carbohydrate (9, 39) . Although strains of S. mutans are phenotypically homogeneous, they display significant heterogeneity by various genetic, biochemical, and serological criteria (15). Bratthall (1) reported the presence of five serotypes, a to e, which were found to be due to unique cell wall-associated carbohydrates. Subsequently, two more serotypes, f and g, have been discovered (33) . Serotype c is the most frequently isolated serotype of S. mutans from human plaque, with serotypes d, e, f, and g being occasionally isolated (11, 33) . S. mutans has also been divided into five species: mutans (serotypes c, e, and f), rattus (serotype b), cricetus (serotype a), sobrinus (serotypes d and g), and ferus (serotype c) (7) . For convenience in this report, we will refer to the strains by their serotype designation.
From both animal models and human dietary studies, it is apparent that cariogenicity is sucrose dependent (13, 37) . There is compelling evidence that water-insoluble glucans produced by extracellular glucosyltransferases, which use sucrose as a substrate, contribute to virulence. Mutants deficient in synthesis of these polymers demonstrate reduced cariogenicity in anim,als (38) . Several other enzymes are involved in sucrose metabolism in S. mutans, but the roles of these remain unclear, as does the exact mechanism(s) of virulence. One approach to the study of these questions involves the use of recombinant DNA methodology to isolate, produce, and further characterize these enzymes.
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Cloning S. mutans genes in Escherichia coli offers the advantage of a sucrose nonutilizing host and the choice of a wider variety of cloning vectors. One group of vectors becoming increasingly more popular'are termed positive-selection vectors (4, 34, 42) . One such vector, pOP203(A2+) (42) , was used as a cloning vehicle in the work described here. These vectors contain genes that are lethal to the host bacterial cell and that contain unique restriction endonuclease sites. When DNA fragments are inserted at one of these sites, expression of the lethal gene is disrupted, and the transformed bacterium survives entry and replication of the plasmid. Hence, recombinant plasmids are directly selected by using these vectors. This paper describes the cloning of a sucrase gene from S. mutans LM7 (serotype e) into E. coli by using the pOP203(A2+) plasmid. Southern (26) , and transformation into Streptococcus sanguis Challis revealed stimulatory effects upon endogenous polysaccharide synthesis and sucrase activity in the resulting S. sanguis transformant.
MATERIALS AND METHODS
Bacterial strains and media. The strains used or constructed in this work are described in Table 1 . Streptococcal strains were grown in brain heart infusion broth (Difco Laboratories, Detroit, Mich.). This broth containing 10% heatinactivated (56°C for 30 min) horse serum was used to grow streptococcal cells to competence for genetic transforma- (6) . E. coli strains were screened rapidly for plasmid DNA as previously described (28) . Streptococcal strains were screened for plasmid DNA by the same method with minor modification (28) . Chromosomal DNA was obtained by using the method of Marmur (30 was transformed to Tcr with pVA868 (41). pVA1120 and pVA868 were incompatible. Transformants selected on medium containing 10 jig of tetracycline per ml were transferred to medium containing 10 ,ug of erythromycin per ml and checked for erythromycin sensitivity. Tcr Ems colonies were examined for plasmid content by agarose gel electrophoresis. Frequency of curing of the pVA1120 plasmid under such conditions was about 25%. Preparation of minicells and electrophoresis analysis of plasmid-encoded proteins. E. coli minicells (strain M2141) were purified and labeled essentially as described by Kennedy et al. (17) , except that before labeling, cycloserine was added to the minicell preparation at a final concentration of 40 ,ug/ml for 90 min at 37°C. Labeling of proteins was performed by incubation with 20 puCi of [35S]methionine (New England Nuclear Corp., Boston, Mass.) in methionine assay media (Difco). Minicell lysates were analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (22) on a 10% polyacrylamide slab gel with a 3% stacking gel. Molecular weight standards were purchased from Pharmacia Fine Chemicals, Piscataway, N.J. Gels were dried, and autoradiography was carried out for 24 h or longer at -70°C with Kodak K-Omat R film.
Preparation of streptococcal protein fractions. S. mutans or S. sanguis strains were grown in 10-ml volumes overnight at 37°C aerobically in chemically defined medium (39; glucose as the carbon source) supplemented with 10 mM sodium bicarbonate. These cultures then were used to inoculate 1 liter of the same medium. Aerobic growth of the cultures at 37°C for 24 to 36 h was allowed to proceed. Cells were harvested by centrifugation at 9,000 x g for 20 min in a Sorvall GSA rotor.
(i) Cellular fractions. The washed cells were resuspended in 10 ml of 10 mM sodium phosphate buffer (pH 6.5) and FIG. 2. Growth of E. coli V871 and V1009 in minimal medium. Cultures were grown overnight in broth. Cells were harvested, washed with buffered saline, and inoculated 1:50 into prewarmed minimal medium containing 1% carbohydrate, 0.5 mM IPTG, and 10 ,ug of thiamine hydrochloride per ml. Growth was at 37°C with aeration, and increase in optical density at 600 nm (OD6w) was measured. Symbols: 0, growth in 1% glucose; A, growth in 1% raffinose; 0, growth in 1% sucrose.
INFECT. IMMUN. were disrupted in a French pressure cell (American Instrument Co., Silver Spring, Md.). This was followed by centrifugation of unbroken cells and cell debris at 3,000 x g and retention of the supernatant.
(ii) Extracellular fractions. (25) , using bovine serum albumin (J. T. Baker Chemical Co., Phillipsburg, N.J.) as the standard. Assays were done by using crude cellular and extracellular extracts as described above. Generation of reducing sugars from sucrose at 37°C was measured by the method of Nelson (32) . Cultures (10 ml) of E. coli were grown overnight, pelleted, washed twice with phosphate-buffered saline and resuspended in 10 ml of saline. Toluene (0.5%, vol/vol) was added, and the tubes were shaken mechanically for 10 min at 37°C. Toluenized cells (1 ml) were mixed with 1.0 ml of 0.2 M sucrose in phosphate-buffered saline and incubated at 37°C. Samples (0.1 ml) were taken every 30 min and assayed as described by Nelson (32) . Streptococcal reducing sugar assays were done with 0.1 ml of intracellular or extracellular preparations in 1.0 ml of 0.1 M sucrose in phosphate-buffered saline. Synthesis of total exopolysaccharides at 37°C from streptococcal extracellular fractions was determined by the method of Germaine et al. (10) . The preparation was added (10 ,ul) to reaction tubes containing 10 
RESULTS
Construction and screening of S. mutans LM7 genomic library. Plasmid pOP203(A2+), a pMB9 Tcr derivative, contains the lactose promoter-operator fused to the Qp phage A2 gene (Fig. 1) , which is lethal to an E. coli host when it is expressed (42) . This gene contains several unique restriction endonuclease sites, including EcoRI. When DNA fragments are inserted at these sites, expression of the A2 gene is insertionally inactivated, and cells containing such recombinant plasmids can survive. This allows for positive selection of tetracycline-resistant recombinants in the presence of IPTG, an inducer of the lactose operon. Chromosomal DNA was isolated from S. mutans LM7, partially digested with EcoRI, and cloned into the EcoRI site of pOP203(A2+). The ligation mixture then was transformed into E. coli V871. Clones then were screened by the procedure of Robeson et al. (35) . Colonies were tested for their ability to ferment raffinose in the presence of IPTG. Raffinose is a trisaccharide which can be cleaved to yield galactose and sucrose or melibiose and fructose. Since E. coli V871 did not hydrolyze sucrose and was galactose nonutilizing, any raffinose fermenters should be capable of sucrose hydrolysis.
Two raffinose-fermenting clones were detected after screening the equivalent of a genomic library as defined by Clarke and Carbon (5) . One such clone, designated V1009, was selected for further study. Figure 2 shows that strain V1009 was capable of limited growth in both minimal sucrose and minimal raffinose media. A toluenized culture of strain V1009 was assayed for the production of reducing (Fig. 7A) . Again, however, these levels were plasmid pVA1120. S. mutans well below those of S. mutans LM7 (data not shown). These were cleaved with EcoRI and charide formation, amounts produced by V1129 were considerably elevated when compared with V857 but again less fragments of pVA1009 then than S. mutans LM7 (Fig. 7B) . Since S. mutans synthesized determine which fragment(s) both glucans and fructans, the preceeding assays were zing gene. This plasmid was repeated with [14C]sucrose labeled in either the glucose or with EcoRI-cleaved pVA856 fructose portion to determine whether one or both were shown in Fig. 4 . Plasmid elevated in S. sanguis V1129. The results of these assays are moter-operator in front of a summarized in Table 3 . First, neither S. sanguis V857 nor determinant (16) . Plasmid V1129 produced fructan. V1129 showed an approximate a shuttle vector capable of twofold increase in total glucan synthesis, and as illustrated, eptococci (26) . The pVA1009 it appeared that almost all of this increase was in the form of Id allowed to ligate to these water-insoluble glucan. A second independently derived iants were used to transform isolate, S. sanguis V1214, displayed the same properties as Colonies then were screened did V1129 (Fig. 7A ). In addition, S. sanguis V1129 was medium, and acid-producing cured of the pVA1120 plasmid by transforming an incompatmid content. AU strains conible plasmid, pVA868 Tcr, into the strain, selecting for Tcr, ombinant plasmids shared a and screening for the Ems phenotype. Both pVA1120 and It insert.
pVA868 cannot simultaneously exist in the same cell since from both V1118 and V1120 both plasmids replicate with the pVA380-1 replicon (26, 41). minicell-producing strain. By A strain (V1213) missing the pVA1120 plasmid was connewly synthesized proteins, structed in this fashion. V1213 displayed in vitro exopolysaclasmid-directed minicell procharide synthesis levels almost identical to those of S. le gel electrophoresis. (Fig. 5, [7 sucrase gene to gtfA. Since similar in size to the gtfA cloned from S. mutans PS14 wished to determine whether iction endonuclease mapping 2.4-kb EcoRl fragment conlentical in size to those found tains the gtfA gene (data not tion was performed by using Lsmid pVA1120 atid chromo--rotypes a to g digested with ilogy to pVA1120 and 2.4-kb id f (Fig. 6 ). When pVA1120 gene(s); however, the use of partially digested chromosomal DNA should have eliminated this problem. Strain V1009 was selected for further study (V1008 was found to be a derivative of V1009). V1009 contained four EcoRI fragments totalling 10.3 kb. This strain was capable of growth in minimal sucrose and minimal raffinose media and hydrolyzed sucrose as determined by the generation of reducing sugar (32) .
The four cloned EcoRI fragments were further analyzed to determine their occurrence in the other S. mutans Bratthall serotypes. We believe that the four EcoRI fragments of pVA1009 are adjacent to each other (i.e., represent a partially digested fragment) on the S. mutans chromosome for the following reasons. First, similar fragment patterns were present in serotype c and f strains as well as in the serotype e LM7 strain (Fig. 3) . These similarities occur despite the obvious differences in the EcoRI fingerprint patterns of these serotypes (Fig. 3A) . It is for this reason that we chose to use the serotype rather than the subspecies division of S. mutans as there are some differences apparent within subspecies at the DNA level. Second, another independently isolated raffinose-fermenting clone, V1008, contained fragments b, c, and d but not fragment a. Third, several raffinose-fermenting clones have been isolated from V403, a serotype c clinical isolate, and they also show either all of the EcoRI fragments or some combination of them (data not shown). These data argue against a random association of EcoRI fragments during the ligation reaction. The data in Fig. 3 Subcloning experiments revealed that the sucrase gene resided within a 2.4-kb EcoRI fragment. This fragment was cloned into plasmids pBH20 and pVA856 as described above, the latter plasmid being capable of replication in both E. coli and streptococci (26) . Restriction endonuclease analysis and minicell protein synthesis analyses yielded data consistent with those obtained with E. coli X1849(pYA601), the strain described by Robeson et al. (35) . A Southern hybridization experiment with pYA601 as a probe against plasmid pVA1120 and chromosomal DNA from S. mutans serotypes a to g indicated homology between the strain LM7 sucrase gene and the gtfA gene under conditions of high stringency. We believe that we have cloned the serotype e allele of the serotype c gtfA gene.
The shuttle plasmid pVA1120 containing the gtfA gene was transformed into S. sanguis Challis. This strain showed increases in both intracellular and extracellular levels of reducing sugar activity when compared with the control strain S. sanguis V857 (which contains the shuttle plasmid pVA856 without gtfA). Similarly, V1129 showed increased glucan synthesis and, upon further study, increased waterinsoluble glucan synthesis. This is significant in that S. sanguis normally produces little detectable water-insoluble glucan (3). An independently obtained second transformant of S. sanguis yielded results similar to those obtained with S. sanguis V1129. Curing pVA1120 from V1129 yielded wildtype S. sanguis exopolysaccharide synthesis levels (Fig.  7A) . These data compellingly associate the glucan synthesis alterations seen in S. sanguis V1129 with the strain LM7 gtfA gene.
Several possibilities can account for these findings. The increased activities can be the result of direct expression of the cloned S. mutans gtfA gene. Alternatively, the cloned gene product might be indirectly affecting expression of a gene(s) already present in S. sanguis. These possibilities are not mutally exclusive. We favor the former notion. Since S. sanguis produces water-soluble glucans (3), the S. mutans cloned gene product may play a role in a branching reaction forming a-1,3 glucosidic linkages. The enzyme might work in association with other glucosyltransferases which have been previously reported (15, 19, 20 ; R. Curtiss III, personal communication). This could account for the production of water-insoluble glucan in the S. sanguis host. It is interesting to note that the cloned gtfA gene of S. mutans PS14 could be demonstrated to synthesize small (MW1500) glucans in E. coli (35) . This observation, taken together with our data, leads to an attractive hypothesis: the gtfA gene product may be specifying the synthesis of a primer glucan that specific glucosyltransferases use in manufacturing water-insoluble glucan.
Since synthesis of water-insoluble glucan seems to be important in virulence, it would be interesting to examine whether S. sanguis V1129 might be pathogenic in an in vivo system. We are proceeding to dissect the biochemistry of the altered glycan synthesis of S. sanguis V1129 by a variety of approaches. We also plan to search for other glucosyltransferase activities in S. mutans LM7 using a lambda genomic library followed by immunological screening of the library with antibiodies raised to extracellular antigenic determinants. Clearly, the application of recombinant DNA methodology to the study of S. mutans should afford us the opportunity to study all of the genetic components of glucan synthesis and help us better understand the nature of this established virulence trait.
